The global blow-fill seal technology market is exhibiting unparalleled expansion; estimates suggest that its valuation will reach US$ 3,246.7 million in 2023 and US$ 6,206.5 million by 2033. Sales ...
Malaria is still a significant public health challenge in Kenya, though some progress may be coming. Parts of Kenya ...
Nigeria recently became the first country to roll out a new vaccine (called Men5CV) recommended by the World Health Organization (WHO), which protects people against five strains of meningococcus ...
Benin, Liberia and Sierra Leone launched large-scale malaria vaccine programmes on Thursday under an Africa-focused ...
Until three years ago nobody had developed a vaccine against any parasitic disease. Now there are two against malaria: the ...
South Korea facility bears the international burden of mass producing oral cholera vaccines to stem an acute stockpile ...
By the time you reach the end of this article, three children will have died from malaria – a disease that casts a dark ...
Until three years ago nobody had developed a vaccine against any parasitic disease. Now there are two against malaria: the ...
23h
Malaria incidents are on the rise. There were 249 million cases of this parasitic disease in 2022, five million more than in ...
Press Release - An estimated 51.2 million lives have been saved through vaccines in the African region over the past 50 years ...
Analysis - Until three years ago nobody had developed a vaccine against any parasitic disease. Now there are two against malaria: the RTS,S and the R21 vaccines.
Pneumococcal Vaccines Market is expected to surpass US$ 13.3 Billion by 2033 to advance at a CAGR of 4.1% from 2023 to 2033.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback